IAI Try JB online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theinert, S. M.
Right arrow Articles by Walden, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theinert, S. M.
Right arrow Articles by Walden, P.
Infection and Immunity, October 2005, p. 7018-7021, Vol. 73, No. 10
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.10.7018-7021.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Identification of New Antigens in Visceral Leishmaniasis by Expression Cloning and Immunoblotting with Sera of Kala-Azar Patients from Bihar, India{dagger}

Stephan M. Theinert,1 Rajatava Basu,2 Michael Forgber,1 Syamal Roy,2 Shyam Sundar,3 and Peter Walden1*

Clinical Research Group, Department of Dermatology, Charité University Medicine Berlin, Humboldt University, D-10089 Berlin, Germany,1 Indian Institute of Chemical Biology, Jadavpur, Calcutta 700032, India,2 Kala-Azar Medical Research Center, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India3

Received 20 August 2004/ Returned for modification 20 November 2004/ Accepted 4 July 2005

Sera of kala-azar patients from Bihar, India, were used to identify Leishmania donovani antigens encoded by a phage expression library. Ten antigens were identified, five of which have not been described as leishmania antigens before. The antigens specifically react with sera of leishmania-infected patients but not of toxoplasma- or plasmodium-infected patients.


* Corresponding author. Mailing address: Department of Dermatology, Charité University Medicine Berlin, Humboldt University, Schumannstr. 20/21, D-10117 Berlin, Germany. Phone: 49-30-450 518 031. Fax: 49-30-450 518 932. E-mail: peter.walden{at}charite.de.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: J. F. Urban, Jr.


Infection and Immunity, October 2005, p. 7018-7021, Vol. 73, No. 10
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.10.7018-7021.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2005 by the American Society for Microbiology. All rights reserved.